Emerging Cancer

Description:

Okay, so I got hit bad by Dendreon, but who didn't? It was worth it to take a chance, especially after the surprisingly positive AC recommendation. But hindsight is 20/20, and I was blinded by message board contributors who didn't see the writing on the wall that pointed towards an approvable letter. But all is not lost if you are a true DNDN long as I still believe that the therapy has potential, and the experience has opened me up to the emerging cancer field, which even has it's own index fund in HHJ. This portfolio keeps track of all the stocks in this field, hopefully separating the wheat from the chaff.

Most Viewed Portfolios

View All

Articles

5 Stocks Poised for Breakouts

05.25.12 | 11:47 AM

 WINDERMERE, Fla. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, ...

8 Stocks Soaring on Big Volume

05.25.12 | 01:13 PM

WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...

More Articles
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter